Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Toremifene with Melatonin or Metformin in Breast Cancer
NCT02506790Phase 2Unknown
- Sponsor
- N.N. Petrov National Medical Research Center of Oncology
- Start
- Jul 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of melatonin and metformin in breast cancer, sponsored by N.N. Petrov National Medical Research Center of Oncology. Status: unknown.
02
Drugs
melatoninmetformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02506790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506790.